首页> 外文OA文献 >Effects in the pulmonary function before single dose of exogenous pulmonary surfactant in children with acute respiratory distress syndrome (ARDS)
【2h】

Effects in the pulmonary function before single dose of exogenous pulmonary surfactant in children with acute respiratory distress syndrome (ARDS)

机译:单次使用外源性肺表面活性物质对急性呼吸窘迫综合征(ARDS)儿童的肺功能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Acute Respiratory Distress Syndrome (ARDS) is a pulmonary lesion of multifactorial cause in which the surfactant system is altered owing to inactivation and impairment of composition and metabolism. The use of exogenous pulmonary surfactant is a therapeutic option with the objective to maintain alveolar stability thus improving the pulmonary compliance (increasing the residual functional capacity), oxygenation and ventilatory mechanics. A study carried out on two pediatric patients with ARDS submitted to mechanic pulmonary ventilation, applying a single dose of exogenous pulmonary surfactant is described. The patients were evaluated using arterial and venous gasometry before and after the use of surfactant, observing increment in oxygenation, reduction of shunt fraction, improvement in ventilation immediately after exogenous pulmonary surfactant instillation and return to the previous situation after 240 minutes in case 1 and 120 minutes in case 2. More prospective clinical and randomized studies are needed to effectively evaluate this therapeutic modality.
机译:急性呼吸窘迫综合征(ARDS)是多因素原因的肺部病变,其中由于失活以及组成和代谢受损,表面活性剂系统发生了改变。使用外源性肺表面活性剂是一种治疗选择,目的是维持肺泡稳定性,从而改善肺顺应性(增加残余功能能力),氧合作用和呼吸机能。描述了对两名接受机械肺通气的小儿ARDS患者进行的研究,该研究应用了单剂量的外源性肺表面活性剂。在使用表面活性剂之前和之后,通过动脉和静脉气体压力法对患者进行评估,观察外源性肺表面活性剂滴注后氧合的增加,分流分数的减少,通气的改善以及在情况1和120后240分钟后恢复到以前的状况在情况2中的分钟数。需要进行更多前瞻性的临床和随机研究以有效评估这种治疗方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号